194 related articles for article (PubMed ID: 12042592)
1. Metamizole use by Latino immigrants: a common and potentially harmful home remedy.
Bonkowsky JL; Frazer JK; Buchi KF; Byington CL
Pediatrics; 2002 Jun; 109(6):e98. PubMed ID: 12042592
[TBL] [Abstract][Full Text] [Related]
2. Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care setting.
Garcia S; Canoniero M; Lopes G; Soriano AO
South Med J; 2006 Sep; 99(9):924-6. PubMed ID: 17004525
[TBL] [Abstract][Full Text] [Related]
3. Paediatric Agranulocytosis Associated with Metamizole Treatment.
Kılıç Ö; İşeri Nepesov M; Ulukapı HB; Özdemir ZC; Bör Ö; Dinleyici EÇ
Paediatr Drugs; 2021 Jan; 23(1):105-110. PubMed ID: 33247375
[TBL] [Abstract][Full Text] [Related]
4. Dipyrone (metamizole) use in the United States: a lethal tango?
Moorman J
South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
[No Abstract] [Full Text] [Related]
5. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
[TBL] [Abstract][Full Text] [Related]
6. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
Lampl C; Likar R
Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
[TBL] [Abstract][Full Text] [Related]
7. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
Klose S; Pflock R; König IR; Linder R; Schwaninger M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
[TBL] [Abstract][Full Text] [Related]
8. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
Lerman TT; Sagi M; Shafir Y; Sheena L; Cohen E; Goldberg E; Krause I
Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
[TBL] [Abstract][Full Text] [Related]
10. [Leukopenia with unclear fever].
Mayer S; Kündiger T; Schrader H
Internist (Berl); 2017 Jul; 58(7):740-744. PubMed ID: 28265684
[TBL] [Abstract][Full Text] [Related]
11. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
Lutz M
J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
[TBL] [Abstract][Full Text] [Related]
12. Chronic use of metamizole: not so safe after all?
Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
[TBL] [Abstract][Full Text] [Related]
13. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
Hoffmann F; Bantel C; Jobski K
Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
[TBL] [Abstract][Full Text] [Related]
14. [Case Report - Metamizole-Induced Agranulocytosis].
Gonnert FA; Meißner W
Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
[TBL] [Abstract][Full Text] [Related]
15. Dipyrone-induced granulocytopenia: a case for awareness.
Garcia S; Canionero M; Lopes G
Pharmacotherapy; 2006 Mar; 26(3):440-2. PubMed ID: 16503727
[TBL] [Abstract][Full Text] [Related]
16. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
[TBL] [Abstract][Full Text] [Related]
18. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
[TBL] [Abstract][Full Text] [Related]
19. [The use of metamizole as a risk factor in the occurrence of agranulocytosis].
Vlakhov V; Bakracheva N; Popova L
Vutr Boles; 1988; 27(2):80-5. PubMed ID: 3046147
[TBL] [Abstract][Full Text] [Related]
20. [Agranulocytosis after use of metamizole - an underestimated risk?].
Schinz K; Waldfahrer F; Wüst W; Iro H
Laryngorhinootologie; 2020 Oct; 99(10):707-712. PubMed ID: 32588405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
